1. To examine mechanisms underlying selective neuronal vulnerability.
2. To examine molecular mechanisms underlying epileptogenesis.
3. To understand the role of pharmacogenomics in the treatment of epilepsy.
03/28/2018 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Charles J. Marcuccilli, PhD, MD